ENTA - CIK 0001177648
ENANTA PHARMACEUTICALS INC has filed 822 documents with the SEC between 2002 and 2026. The most frequent type is insider trade (435 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| EFFECT | - | 2024-02-08 | - |
| Quarterly report | 10-Q | 2024-02-08 | 2023-12-31 |
| Major company event | 8-K | 2024-02-07 | 2024-02-07 |
| SEC correspondence | UPLOAD | 2024-02-07 | - |
| Company correspondence | CORRESP | 2024-02-06 | - |
| Annual report to shareholders | ARS | 2024-01-26 | 2023-09-30 |
| Proxy materials | DEFA14A | 2024-01-26 | - |
| Proxy statement | DEF 14A | 2024-01-26 | 2024-03-06 |
| Passive ownership stake (update) | SC 13G/A | 2024-01-26 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-24 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-22 | - |
| Passive ownership stake | SC 13G | 2024-01-11 | - |
| Major company event | 8-K | 2023-12-26 | 2023-12-19 |
| Insider trade | 4 | 2023-12-15 | 2023-12-13 |
| Insider sale notice | 144 | 2023-12-12 | - |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-06 | 2023-12-05 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| Insider trade | 4 | 2023-12-05 | 2023-12-01 |
| SEC correspondence | UPLOAD | 2023-11-27 | - |
| Securities registration | S-3 | 2023-11-22 | - |
| POSASR | - | 2023-11-22 | - |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Insider trade | 4 | 2023-11-22 | 2023-11-22 |
| Annual report | 10-K | 2023-11-22 | 2023-09-30 |
| Major company event | 8-K | 2023-11-20 | 2023-11-20 |
| Passive ownership stake | SC 13G | 2023-11-16 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-10-06 | - |
| Employee stock plan | S-8 | 2023-08-08 | - |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Major company event | 8-K | 2023-08-07 | 2023-08-07 |
| Major company event | 8-K | 2023-06-07 | 2023-06-07 |
| Quarterly report | 10-Q | 2023-05-09 | 2023-03-31 |
| Major company event | 8-K | 2023-05-08 | 2023-05-08 |
| Major company event | 8-K | 2023-04-27 | 2023-04-25 |
| Insider trade | 4 | 2023-04-19 | 2023-04-18 |